Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2014 · fourth_quarter · Health Issues
Bills with similar content found using semantic analysis.
Sources: Congress.gov
S2645 & HR2536 Recovery Enhancement for Addiction Treatment Act - Patient Caps
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
S2645 & HR2536 Recovery Enhancement for Addiction Treatment Act - Patient Caps
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Tariff (miscellaneous tariff bills)
S.2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S.2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S.2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S.2642 - A bill to suspend temporarily the duty on certain polycrystalline fibers S.2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluorpropylene, and vinylidene fluoride. S.2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S.2639 - A bill to suspend temporarily the duty on bisphenol A Bis (3-methacryloyloxypropyl) either substituted dimethacylate. S.2638 - A bill to suspend temporarily the duty on copoly (acrylic acid/itaconic acid). S.2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S.2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon armines, and/or perfluorocarbon ethers. S.2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbon alkanes. S.2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,500,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2014 · fourth_quarter · Health Issues
S2645 & HR2536- Recovery Enhancement for Addiction Treatment Act - Patient Caps
Client expense: Not reported · Firm income: Not reported
2014 · fourth_quarter · Pharmacy
S2645 & HR2536- Recovery Enhancement for Addiction Treatment Act - Patient Caps
Client expense: Not reported · Firm income: Not reported
2014 · fourth_quarter · Health Issues
Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions and prescription drug abuse. 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Delivering Antimicrobial Transparency in Animals Act of 2013 (H.R. 820) 7.Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Healthier Lifestyles and Prevention America Act (S. 39) 9.Promoting Health as Youth Skills in Classrooms and Life Act (S. 392/H.R. 2160) 10.Medicare Diabetes Prevention Act (S. 452/H.R. 962) 11.Personal Health Investment Today Act (H.R. 956) 12.A bill to provide for a sequester replacement (S. 16/S. 799) 13.American Family Economic Protection Act of 2013 (S. 388) 14.Consolidated and Further Continuing Appropriations Act, 2013 (H.R. 933/Public Law 113-6) 15.Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (Public Law 113-5) 16.National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539) 17.Physical Activity Guidelines for Americans Act (S. 531/H.R. 2179) 18.Firearm Safety and Public Health Research Act (H.R. 321) 19.Energy Consumers Relief Act (S. 1363/H.R. 1582) 20.Common Sense Nutrition Disclosure Act (H.R. 1249/S. 1756) 21.Improve Nutrition Program Integrity and Deficit Reduction Act (S. 458/H.R. 1510) 22.A bill to amend the Food and Nutrition Act of 2008 to improve the supplemental nutrition assistance program (S. 762/H.R. 1657) 23.Agriculture Reform, Food, and Jobs Act (S. 954/H.R. 2498) 24.Federal Agriculture Reform and Risk Management Act (H.R. 1947) 25.FIT Kids Act (S. 1033/H.R. 2178) 26.Strengthening Americas Schools Act (S. 1094) 27.Access to Quality Diabetes Education Act (S. 945/H.R. 1274) 28.Fit to Serve Act (S. 976) 29.Climate Change Health Protection and Promotion Act (H.R. 2023/S. 2864) 30.Treat and Reduce Obesity Act (S. 1184 / H.R. 2415) 31.Student Success Act (H.R. 5) 32.To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act (H.R. 45) 33.Medicare Better Health Rewards Program Act (S. 1228/H.R. 2524) 34.Senate FY14 Labor, Health and Human Services, and Education Bill (S. 1284) 35.House of Representatives FY14 Labor, Health and Human Services, and Education Bill 36.Pharmacy Compounding Quality and Accountability Act (S. 959) 37.Safeguarding Americas Pharmaceuticals Act (H.R. 1919) 38.Implementation of Drug Supply Chain Security Act (P.L. 113-54) 39.Preservation of Antibiotics for Medical Treatment Act (H.R. 1150)/Preventing Antibiotic Resistance Act of 2013 (S. 1256) 40.Healthy Families Act (H.R. 1286/S. 631) 41.FY2014 Continuing Resolution (H.J. Res. 59) 42.Pharmaceutical Quality, Security and Accountability Act (S. 959) 43.Energy Consumers Relief Act (S. 1363/H.R. 1582) 44.Increasing the Safety of Prescription Drug Use Act (S. 1657) 45.National Energy Tax Repeal Act (S. 1324) 46.Saving Coal Jobs Act of 2013 (S. 1514/H.R. 5077) 47.Community Parks Revitalization Act (H.R. 2424) 48.A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings (S. 1422/H.R. 2663) 49.School-based Health Centers Program Reauthorization Act of 2013 (H.R. 2632) 50.Nutrition Reform and Work Opportunity Act (H.R. 3102) 51.Health Equity and Accountability Act (H.R. 5294) 52.Secure America for Education (SAFE) in Our Schools Act of 2013 (H.R. 3158) 53.Continuing Appropriations Resolution, 2014 (H.J. Res 59) 54.Continuing Resolution FY 2014 (HR 2775, PL 113-46) 55.A bill to amend title 23, United States Code, with respect to the establishment of performance measures for the highway safety improvement program, and for other purposes. (H.R. 3493/S. 1708) 56.The Farm Bill (S. (S. 954/H.R. 2498; H.R. 1947, and H.R. 3102, Public Law 113-79) 57.Better Care, Lower Cost Act (S. 1932/H.R. 3890) 58.Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) (H.R. 3742) 59.The Consolidated Appropriations Act of 2014 (H.R. 3547/Public Law 113-76 60.Strategies to Address Antimicrobial Resistance (STAAR) Act (S. 2236/H.R. 2285) 61.New Opportunities for Bicycling and Pedestrian Infrastructure Financing Act of 2014 (H.R. 3978) 62.Eliminating Disparities in Diabetes Prevention, Access, and Care Act (H.R. 3322) 63.Electricity Security and Affordability Act (S. 1905/H.R. 3826) 64.Stop Overdose Stat Act (HR 4169) 65.Overdose Prevention Act (S 2755) 66.Opioid Overdose Reduction Act (S. 2092/H.R. 4288) 67.Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 (DISARM Act) (H.R. 4187) 68.Child Care and Development Block Grant Act of 2014 (S. 1086) 69.Departments of Labor, Health and Human Services and Education And Related Agencies Fiscal Year 2015 Appropriations Bill (including H.R. 5464) 70.Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 (S. 2389 / H.R. 4800) 71.Department of the Interior, Environment, and Related Agencies appropriations legislation, 2015 (including H.R. 5171) 72.MAP-21 Reauthorization Act (S. 2322) 73.Stop Subsidizing Childhood Obesity Act (S. 2342/H.R. 2831) 74.ENRICH Act (H.R. 4427) 75.Healthy Kids Outdoors Act of 2014 (S. 2367/H.R. 4706) 76.Summer Meals Act of 2014 (S. 2527/HR. 5012) 77.Long-Term SCORE Act (H.R. 4444) 78.American Cures Act (S. 2115/H.R. 4384) 79.A joint resolution to disapprove a rule of the Environmental Protection Agency relating to greenhouse gas emissions from electric utility generating units. (S.J. Res 30) 80.Fit for Life Act of 2014 (H.R.4765) 81.School Food Modernization Act (S. 2210/H.R. 1783) 82.Protecting Children from Electronic Cigarette Advertising Act of 2014 (S. 2014/H.R. 4325) 83.Pedestrian Safety Act of 2014 (S. 2284) 84.Safe Streets Act of 2014 (S. 2004/H.R. 2468) 85.Time for Recovery Enhancement for Addiction Treatment Act (S. 2645) 86.FY 2015 Financial Services and General Government Appropriations bill, in support of an appropriation for the National Alliance for Model State Drug Laws (including H.R. 5016) 87.Vector-Borne Disease Research Accountability and Transparency Act (H.R. 4701) 88.Highway and Transportation Funding Act of 2014 (H.R. 5021/Public Law 113-159) 89.Full-Service Community Schools Act of 2014 (H.R. 5168) 90.PREPARE Act of 2014 (H.R. 5314) 91.Waters of the United States Regulatory Overreach Protection Act of 2014 (S. 2496/H.R. 5078) 92.American Energy Solutions for Lower Costs and More American Jobs Act (H.R. 2) 93.FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act (H.R. 83/Public Law 113-234) 94.Promise for Antibiotics and Therapeutics for Health Act (PATH Act, S. 2996) 95.Infectious Disease Hospital Hubs Act (S. 2942)
2014 · fourth_quarter · Health Issues
S. 2839, Comprehensive Addiction and Recovery Act of 2014, all provisions S. 2645, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions H.R. 5481, To continue the use of a 3-month quarter EHR reporting period for health care providers to demonstrate meaningful use for 2015 under the Medicare and Medicaid EHR incentive payment programs, and for other purposes, all provisions H.R. 1074, National Diabetes Clinical Care Commission Act, all provisions S. 539, National Diabetes Clinical Care Commission Act, all provisions H.R. 1701, Cutting Costly Codes Act of 2013, all provisions S. 972, Cutting Costly Codes Act of 2013, all provisions Affordable Care Act - implementation Ebola Prescription requirements for OTC medications Electronic Health Records - Meaningful Use ICD-10 Repeal Prescription Drug Diversion Prescription drug abuse/pain management/prescriber education Telemedicine Sunshine Act Laboratory Developed Tests 21st Century Cures Initiative Narrow Networks Mental Health Diabetes Antibiotics and data collection Personalized medicine Coverage of lung cancer screening for high-risk patients Drug Quality and Security Act/Compounded and Repackaged Medications Federal scientists and researchers - academic and scientific conference travel restrictions Men who have sex with men/blood donor deferral policy
Client expense: $4,390,000 · Firm income: Not reported
2014 · fourth_quarter · Health Issues
H.R.5464 and draft Senate legislation, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015, Title II H.R. 83, P.L.113-235, Consolidated and Further Continuing Appropriations Act, 2015, Division G, Title II Issues: Support funding for NIH, Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Children's Hospitals Graduate Medical Education program (CHGME), HRSA, biodefense and public health preparedness programs, and CDC's National Healthcare Safety Network (NHSN) and the Prevention Epicenters Program. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. Support emergency supplemental funding to prepare and respond to Ebola and to reimburse for Ebola Virus Disease treatment. H.R. 4486 and draft Senate legislation, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2015, Title II H.R. 83, P.L.113-235, Consolidated and Further Continuing Appropriations Act, 2015, Division I, Title II President's Budget, FY 2016 Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. Issue: Funding for Community Health Centers and the NHSC. Debt in Health Education Loan programs (DebtHELP) bill (draft) Issues: Expand National Health Service Corps State Loan Repayment program, align Department of Education and Health Resources and Services Administration student loan programs. S. 577, Resident Physician Shortage Reduction Act of 2013 H.R. 1180, Resident Physician Shortage Reduction Act of 2013 Issue: Support lifting the cap on the number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education and Indirect Medical Education payments. H.R. 1201, Training Tomorrow's Doctors Today Act Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments and increase Graduate Medical Education (GME) accountability and transparency. H.R. 487, Primary Care Workforce Access Improvement Act Issue: Residency training in community-based settings. P.L. 111-148, Affordable Care Act, Sections 5503 and 5506 Issue: Redistribution of residency positions. Issue: Implementation of and funding for Teaching Health Center Graduate Medical Education program under section 340G of the Public Health Service Act. Issue: Development and implementation of new Medicare Disproportionate Share Hospital (DSH) formula required under the Affordable Care Act. H.R. 2810/S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013. Issues: Support repeal of Medicare's sustainable growth rate (SGR) formula; Medicare physician payment reform. Issue: Support the use of animals in medical research. S. 2553/H.R. 4994, Improving Medicare Post-Acute Care Transformation Act of 2014 Issue: Standardization of post-acute care assessment data for quality, payment, and discharge planning. Issue: Promote interprofessional education and training of the health care workforce. Issue: Support funding for the National Healthcare Workforce Commission. Issue: Implementation of Health Insurance Exchanges mandated by the Affordable Care Act (ACA) to recognize and not penalize the unique missions of medical schools and teaching hospitals. Issue: Oppose reduction in Medicare hospital outpatient department reimbursement. Issue: Oppose discretionary spending cuts through sequestration, including NIH, Titles VII and VIII health professions and nursing education programs, and other science programs. Issue: Support primary care workforce development S. 1759, Teaching Health Center Reauthorization Act Issue: Legislation to reauthorize the Teaching Health Center Program and payments. Issue: Draft legislation on pain education in undergraduate and graduate medical education. H.R.548/S. 1152, The Building A Health Care Workforce for the Future Act Issue: Support bill to increase scholarship opportunities for medical students and encourage primary care workforce development. H.R. 5294, Health Equity and Accountability Act of 2014 Issue: Support bill to improve health equity. Issue: Oppose inclusion of Medicare add-on payments in Hospital-Acquired Condition (HAC) program. H.R. 3698, Two Midnight Rule Delay Act of 2013 S. 2082, Two Midnight Rule Coordination and Improvement Act of 2014 Issue: Support delay of enforcement of new CMS inpatient criteria (e.g., "Two-Midnight" rule) in FY 2014 Inpatient Prospective Payment System (IPPS) final rule. Issue: Support Medicare GME per Resident Amount and cap trigger technical corrections and administrative relief. H.R. 4188, Establishing Beneficiary Equity in the Hospital Readmissions Program Act. S. 2501, Hospital Readmission Accuracy and Accountability Act. Issue: Support inclusion of socioeconomic status as part of hospital readmissions program, including support for adoption of National Quality Forum (NQF) recommendations. Issue: Educating health professionals regarding prescription drug abuse and appropriate use of antibiotics. Issue: Support report language and efforts of HHS agencies to support efforts of urban-based institutions to improve health equity. Support use of holistic review in admissions. Issue: Support ACA consumer outreach and enrollment efforts. Issue: Implementation of the 340B drug discount program. Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending. Issue: Support preservation of funding for the Primary Care Residency Expansion program. S. 2229, Expanding Primary Care Access and Workforce Act Issue: Offer comments on primary care workforce legislation. H.R. 5411, Trafficking Awareness Training for Health Care Act of 2014 Issue: Medical education curricula content pertaining to human trafficking. S. 2658/H.R.5580, Accelerating Biomedical Research Act Issue: To increase discretionary spending cap to increase funding for the National Institutes of Health (NIH). S. 2450, Veterans' Access to Care through Choice, Accountability, and Transparency Act H.R. 4810, Veteran Access to Care Act Issue: Addressing VA backlogs by increasing care for veterans provided by non-VA facilities. S. 2115, American Cures Act H.R. 4384, America HEALS ACT Issue: Support establishment of a fund to provide an expanded and sustained investment in biomedical research. H.R. 4879, Research for All Act Issues: Support inclusion of male and female cells, tissues and animals in basic biomedical research. Support update of NIH guidelines to increase participation of women in clinical trials. Issue: FDA regulation of Laboratory Developed Tests (LDTs) S. 2728, Community Based Medical Education Act of 2014 Issue: Oppose reduction of Medicare GME/IME payments S. 2645, The Recovery Enhancement for Addiction Treatment (TREAT) Act Issue: Support legislation to increase access to care for patients addicted to opioids S. 2942, The Infectious Disease Hospitals Hubs Act Issue: Support legislation to establish a network of hospitals in preparing for and responding to infectious diseases. Issue: Support nomination of Dr. Vivek Murthy as U.S. Surgeon General Draft Hospital Improvements for Payment (HIP) Act of 2014 Issues: Support repeal of CMS Two-Midnights Rule, extending RAC audit moratorium for short stays, and permanent bundle program. Issue: Oppose further delays in the implementation of the ICD-10 system Submitted comments to: U.S. Census Bureau on the American Community Survey CMS on the Hospital Acquired Conditions Reduction Program (HAC)s technical expert panel (TEP)s report regarding the scoring of hospitals in the HAC program CMS on final rule regarding definition of uninsured for purposes of Medicaid DSH limits HHS on revisions to the safe harbors under the anti-kickback statute and civil monetary penalty rules (gainsharing, etc.) FDA on strategies for increasing patient involvement in regulatory processes. White House Ebola Response Coordinator offering to work with federal and state officials to prepare and respond to Ebola cases. NIH in response to an RFI related to the development of grant program to help facilitate the transition from training to independence. NIH on the consideration of sex as a biological variable in biomedical research The Patient-Centered Outcomes Research Institute (PCORI) on the proposed process for peer review and public release of its primary research finding. DEA on delaying the Disposal of Controlled Substances Final Rule.
2014 · fourth_quarter · Tariff (miscellaneous tariff bills)
S.2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S.2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S.2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S.2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS.2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluorpropylene, and vinylidene fluoride. S.2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S.2639 - A bill to suspend temporarily the duty on bisphenol A Bis (3-methacryloyloxypropyl) either substituted dimethacylate. S.2638 - A bill to suspend temporarily the duty on copoly (acrylic acid/itaconic acid). S.2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S.2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon armines, and/or perfluorocarbon ethers. S.2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbon alkanes. S.2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,500,000 · Firm income: Not reported
2014 · fourth_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Implementation of addiction treatment issues. Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity Public Law 111-148, Patient Protection and Affordable Care Act, Implementation of addiction treatment issues. Prescription Drug abuse issues. S.2092/H.R.4288, Opioid Overdose Reduction Act of 2014, Access to Naloxone S.348/H.R.672, Prescription Drug Abuse Prevention and Treatment Act of 2013, Prescription drug abuse related issues S.2504, A bill to address prescription opioid and heroin abuse, generally S.2645, TREAT Act, Addiction treatment and recovery issues; 100 patient limit for buprenorphine prescribers S.2839, Comprehensive Addiction and Recovery Act of 2014, Prescription opioid abuse and heroin use treatment issues Addition to #17 below: Center for Substance Abuse Treatment (CSAT)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2014 · fourth_quarter · Health Issues
SGR : Repeal of the current Medicare Physician Payment Formula including: H.R. 4015/S.2000 : SGR Repeal and Medicare Provider Payment Modernization Act of 2014 Revisions to Face to Face documentation requirements for home care under Medicare HR 5539- Legislative changes to the reporting requirements under the Sunshine Act S. 2964 - Ensuring Access to Primary Care for Women and Children Act. S. 2942 - Infectious Diseases Hospital Hub Act - Funding for treatment of Ebola and infectious diseases HR 4888 - The Coordinated Recovery Initiative for Babies (CRIB) Act - collecting data and developing protocols for treating newborns with Neonatal Abstinence Syndrome S 2645 - The Recovery Enhancement Treatment Act allowing qualified MDs and other health care professionals to treat a greater number of opioid addicted patients with medications
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
SGR : Repeal of the current Medicare Physician Payment Formula including: H.R. 4015/S.2000 : SGR Repeal and Medicare Provider Payment Modernization Act of 2014 Revisions to Face to Face documentation requirements for home care under Medicare HR 5539- Legislative changes to the reporting requirements under the Sunshine Act S. 2964 - Ensuring Access to Primary Care for Women and Children Act. S. 2942 - Infectious Diseases Hospital Hub Act - Funding for treatment of Ebola and infectious diseases HR 4888 - The Coordinated Recovery Initiative for Babies (CRIB) Act - collecting data and developing protocols for treating newborns with Neonatal Abstinence Syndrome S 2645 - The Recovery Enhancement Treatment Act allowing qualified MDs and other health care professionals to treat a greater number of opioid addicted patients with medications
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Alcohol and Drug Abuse
HR 4888 - The Coordinated Recovery Initiative for Babies (CRIB) Act - collecting data and developing protocols for treating newborns with Neonatal Abstinence Syndrome S 2645 - The Recovery Enhancement Treatment Act allowing qualified MDs and other health care professionals to treat a greater number of opioid addicted patients with medications
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; and community-based public health interventions and prescription drug abuse. 1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148)2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Delivering Antimicrobial Transparency in Animals Act of 2013 (H.R. 820) 7.Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Healthier Lifestyles and Prevention America Act (S. 39) 9.Promoting Health as Youth Skills in Classrooms and Life Act (S. 392/H.R. 2160) 10.Medicare Diabetes Prevention Act (S. 452/H.R. 962) 11.Personal Health Investment Today Act (H.R. 956) 12.A bill to provide for a sequester replacement (S. 16/S. 799) 13.American Family Economic Protection Act of 2013 (S. 388) 14.Consolidated and Further Continuing Appropriations Act, 2013 (H.R. 933/Public Law 113-6) 15.Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (Public Law 113-5) 16.National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539) 17.Physical Activity Guidelines for Americans Act (S. 531/H.R. 2179) 18.Firearm Safety and Public Health Research Act (H.R. 321) 19.Energy Consumers Relief Act (S. 1363/H.R. 1582) 20.Common Sense Nutrition Disclosure Act (H.R. 1249/S. 1756) 21.Improve Nutrition Program Integrity and Deficit Reduction Act (S. 458/H.R. 1510) 22.A bill to amend the Food and Nutrition Act of 2008 to improve the supplemental nutrition assistance program (S. 762/H.R. 1657) 23.Agriculture Reform, Food, and Jobs Act (S. 954/H.R. 2498) 24.Federal Agriculture Reform and Risk Management Act (H.R. 1947) 25.FIT Kids Act (S. 1033/H.R. 2178) 26.Strengthening Americas Schools Act (S. 1094) 27.Access to Quality Diabetes Education Act (S. 945/H.R. 1274) 28.Fit to Serve Act (S. 976) 29.Climate Change Health Protection and Promotion Act (H.R. 2023/S. 2864) 30.Treat and Reduce Obesity Act (S. 1184 / H.R. 2415) 31.Student Success Act (H.R. 5) 32.To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act (H.R. 45) 33.Medicare Better Health Rewards Program Act (S. 1228/H.R. 2524) 34.Senate FY14 Labor, Health and Human Services, and Education Bill (S. 1284) 35.House of Representatives FY14 Labor, Health and Human Services, and Education Bill 36.Pharmacy Compounding Quality and Accountability Act (S. 959) 37.Safeguarding Americas Pharmaceuticals Act (H.R. 1919) 38.Implementation of Drug Supply Chain Security Act (P.L. 113-54) 39.Preservation of Antibiotics for Medical Treatment Act (H.R. 1150)/Preventing Antibiotic Resistance Act of 2013 (S. 1256) 40.Healthy Families Act (H.R. 1286/S. 631) 41.FY2014 Continuing Resolution (H.J. Res. 59) 42.Pharmaceutical Quality, Security and Accountability Act (S. 959) 43.Energy Consumers Relief Act (S. 1363/H.R. 1582) 44.Increasing the Safety of Prescription Drug Use Act (S. 1657) 45.National Energy Tax Repeal Act (S. 1324) 46.Saving Coal Jobs Act of 2013 (S. 1514/H.R. 5077) 47.Community Parks Revitalization Act (H.R. 2424) 48.A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings (S. 1422/H.R. 2663) 49.School-based Health Centers Program Reauthorization Act of 2013 (H.R. 2632) 50.Nutrition Reform and Work Opportunity Act (H.R. 3102) 51.Health Equity and Accountability Act (H.R. 5294) 52.Secure America for Education (SAFE) in Our Schools Act of 2013 (H.R. 3158) 53.Continuing Appropriations Resolution, 2014 (H.J. Res 59) 54.Continuing Resolution FY 2014 (HR 2775, PL 113-46) 55.A bill to amend title 23, United States Code, with respect to the establishment of performance measures for the highway safety improvement program, and for other purposes. (H.R. 3493/S. 1708) 56.The Farm Bill (S. (S. 954/H.R. 2498; H.R. 1947, and H.R. 3102, Public Law 113-79) 57.Better Care, Lower Cost Act (S. 1932/H.R. 3890) 58.Antibiotic Development to Advance Patient Treatment Act of 2013 (ADAPT Act) (H.R. 3742) 59.The Consolidated Appropriations Act of 2014 (H.R. 3547/Public Law 113-76 60.Strategies to Address Antimicrobial Resistance (STAAR) Act (S. 2236/H.R. 2285) 61.New Opportunities for Bicycling and Pedestrian Infrastructure Financing Act of 2014 (H.R. 3978) 62.Eliminating Disparities in Diabetes Prevention, Access, and Care Act (H.R. 3322) 63.Electricity Security and Affordability Act (S. 1905/H.R. 3826) 64.Stop Overdose Stat Act (HR 4169) 65.Overdose Prevention Act (S 2755) 66.Opioid Overdose Reduction Act (S. 2092/H.R. 4288) 67.Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 (DISARM Act) (H.R. 4187) 68.Child Care and Development Block Grant Act of 2014 (S. 1086) 69.Departments of Labor, Health and Human Services and Education And Related Agencies Fiscal Year 2015 Appropriations Bill (including H.R. 5464) 70.Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015 (S. 2389 / H.R. 4800) 71.Department of the Interior, Environment, and Related Agencies appropriations legislation, 2015 (including H.R. 5171) 72.MAP-21 Reauthorization Act (S. 2322) 73.Stop Subsidizing Childhood Obesity Act (S. 2342/H.R. 2831) 74.ENRICH Act (H.R. 4427) 75.Healthy Kids Outdoors Act of 2014 (S. 2367/H.R. 4706) 76.Summer Meals Act of 2014 (S. 2527/HR. 5012) 77.Long-Term SCORE Act (H.R. 4444) 78.American Cures Act (S. 2115/H.R. 4384) 79.A joint resolution to disapprove a rule of the Environmental Protection Agency relating to greenhouse gas emissions from electric utility generating units. (S.J. Res 30) 80.Fit for Life Act of 2014 (H.R.4765) 81.School Food Modernization Act (S. 2210/H.R. 1783) 82.Protecting Children from Electronic Cigarette Advertising Act of 2014 (S. 2014/H.R. 4325) 83.Pedestrian Safety Act of 2014 (S. 2284) 84.Safe Streets Act of 2014 (S. 2004/H.R. 2468) 85.The Recovery Enhancement for Addiction Treatment Act (S. 2645) 86.FY 2015 Financial Services and General Government Appropriations bill, in support of an appropriation for the National Alliance for Model State Drug Laws (including H.R. 5016) 87.Vector-Borne Disease Research Accountability and Transparency Act (H.R. 4701) 88.Highway and Transportation Funding Act of 2014 (H.R. 5021/Public Law 113-520) 89.Full-Service Community Schools Act of 2014 (H.R. 5168) 90.PREPARE Act of 2014 (H.R. 5314) 91.Waters of the United States Regulatory Overreach Protection Act of 2014 (S. 2496/H.R. 5078) 92.American Energy Solutions for Lower Costs and More American Jobs Act (H.R.
2014 · third_quarter · Tariff (miscellaneous tariff bills)
S.2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S.2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S.2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S.2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS.2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluorpropylene, and vinylidene fluoride. S.2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S.2639 - A bill to suspend temporarily the duty on bisphenol A Bis (3-methacryloyloxypropyl) either substituted dimethacylate. S.2638 - A bill to suspend temporarily the duty on copoly (acrylic acid/itaconic acid). S.2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S.2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon armines, and/or perfluorocarbon ethers. S.2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbon alkanes. S.2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,300,000 · Firm income: Not reported
2014 · third_quarter · Health Issues
Draft House and Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015, Title II H.R.5464, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015, Title IIIssues: Support funding for National Institutes of Health (NIH), Title VII and Title VIII health professions and nursing education programs, Agency for Healthcare Research and Quality (AHRQ), National Health Service Corps (NHSC), Children's Hospitals Graduate Medical Education program (CHGME), Health Resources and Services Administration (HRSA), biodefense and public health preparedness programs, and CDC's National Healthcare Safety Network (NHSN) and the Prevention Epicenters Program. Maintain NIH salary cap at Executive Level II. Encourage the highest possible allocation for the Labor-HHS Subcommittee. H.R. 4486 and draft Senate, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2015, Title II President's Budget, FY 2016 Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. Issue: Funding for Community Health Centers and the National Health Service Corps. Debt in Health Education Loan programs (Debt HELP) bill (draft) Issues: Expand National Health Service Corps State Loan Repayment program, align Department of Education and Health Resources and Services Administration student loan programs. S. 577, Resident Physician Shortage Reduction Act of 2013 H.R. 1180, Resident Physician Shortage Reduction Act of 2013 Issue: Support lifting the cap on the number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education and Indirect Medical Education payments. H.R. 1201, Training Tomorrow's Doctors Today Act Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments and increase Graduate Medical Education (GME) accountability and transparency. P.L. 111-148, Patient Protection and Affordable Care Act, Title V Issue: Reauthorizing National Health Service Corps Fund. H.R. 487, Primary Care Workforce Access Improvement Act Issue: Residency training in community-based settings. P.L. 111-148, Affordable Care Act, Sections 5503 and 5506 Issue: Redistribution of residency positions. Issue: Implementation of and funding for Teaching Health Center Graduate Medical Education program under section 340G of the Public Health Service Act. Issue: Development and implementation of new Medicare Disproportionate Share Hospital (DSH) formula required under the Affordable Care Act. H.R. 2810/S. 1871, SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013. Issues: Support repeal of Medicare's sustainable growth rate (SGR) formula; Medicare physician payment reform. Issue: Support the use of animals in medical research. S. 2553/H.R. 4994, Improving Medicare Post-Acute Care Transformation Act of 2014 Issue: Standardization of post-acute care assessment data for quality, payment, and discharge planning. Issue: Promote interprofessional education and training of the health care workforce. Issue: Support funding for the National Healthcare Workforce Commission.Issue: Implementation of Health Insurance Exchanges mandated by the Affordable Care Act (ACA) to recognize and not penalize the unique missions of medical schools and teaching hospitals. Issue: Oppose reduction in Medicare hospital outpatient department reimbursement. Issue: Oppose discretionary spending cuts through sequestration, including NIH, Titles VII and VIII health professions and nursing education programs, and other science programs. Issue: Support primary care workforce development S. 1759, Teaching Health Center Reauthorization Act Issue: Legislation to reauthorize the Teaching Health Center Program and payments. Issue: Draft legislation on pain education in undergraduate and graduate medical education. H.R.548/S. 1152, The Building A Health Care Workforce for the Future Act Issue: Support bill to increase scholarship opportunities for medical students and encourage primary care workforce development. H.R. 5294, Health Equity and Accountability Act of 2014 Issue: Support bill to improve health equity. Issue: Oppose implementation of Hospital-Acquired Condition (HAC) program and inclusion of Medicare add-on payments in HAC reduction program and penalties. H.R. 3698, Two Midnight Rule Delay Act of 2013 S. 2082, Two Midnight Rule Coordination and Improvement Act of 2014 Issue: Support delay of enforcement of new Centers for Medicare and Medicaid Services (CMS) inpatient criteria (e.g., "Two-Midnight" rule) in FY 2014 Inpatient Prospective Payment System (IPPS) final rule. Issue: Support Medicare Graduate Medical Education (GME) per Resident Amount and cap trigger technical corrections and administrative relief. H.R. 4188, Establishing Beneficiary Equity in the Hospital Readmissions Program Act. S. 2501, Hospital Readmission Accuracy and Accountability Act. Issue: Support inclusion of socioeconomic status as part of hospital readmissions program, including support for adoption of National Quality Forum (NQF) recommendations. President's Budget, FY 2015 Issues: Oppose proposed reductions in Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments; Oppose use of Medicare GME funding for creation of new GME grant program; oppose elimination of Children's Hospitals GME program. Issue: Legislation on educating health professionals regarding appropriate use of antibiotics. H.R. 4427, Enrich Act Draft Senate legislation Issue: Educating health professionals on nutrition.Issue: Support report language and efforts of HHS agencies to support efforts of urban-based institutions to improve health equity. Support use of holistic review in admissions. Issue: Support ACA consumer outreach and enrollment efforts. Issue: Implementation of the 340B drug discount program. Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending. Issue: Support preservation of funding for the Primary Care Residency Expansion program. S. 2229, Expanding Primary Care Access and Workforce Act Issue: Offer comments on primary care workforce legislation. H.R. 5411, Trafficking Awareness Training for Health Care Act of 2014 Issue: Medical education curricula content pertaining to human trafficking. S. 2658/H.R.5580, Accelerating Biomedical Research Act Issue: To increase discretionary spending cap to increase funding for the National Institutes of Health (NIH). H.R. 4942, Underserved Veterans Access to Health Care Act Issue: Support increasing funding for VA GME and Medicare GME. S. 2450, Veterans' Access to Care through Choice, Accountability, and Transparency Act H.R. 4810, Veteran Access to Care Act Issue: Addressing VA backlogs by increasing care for veterans provided by non-VA facilities. S. 2115, American Cures Act H.R. 4384, America HEALS ACT Issue: Support establishment of a fund to provide an expanded and sustained investment in biomedical research. H.R. 4879, Research for All Act Issues: Support inclusion of male and female cells, tissues and animals in basic biomedical research. Support update of National Institutes of Health (NIH) guidelines to increase participation of women in clinical trials. Issue: FDA regulation of laboratory-derived tests S. 2728, Community Based Medical Education Act of 2014 Issue: Oppose reduction of Medicare GME/IME payments S. 2645, The Recovery Enhancement for Addiction Treatment (TREAT) Act Issue: Support legislation to increase access to care for patients addicted to opioids Submitted comments to: the Food and Drug Administration responding to draft guidance entitled Informed Consent Information Sheet: Guidance for IRBs, Clinical Investigators, and Sponsors. Centers for Medicare and Medicaid Services (CMS) on the CY 2015 Physician Fee Schedule Proposed Rule. Centers for Medicare and Medicaid Services (CMS) on the CY 2015 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Centers for Medicare and Medicaid Services (CMS) in support of additional transparency and comment opportunity in the valuation of physician and other healthcare professional services. the Centers for Medicare and Medicaid Services (CMS) to express concern of the delays and complications in the Open Payments Review and Dispute Process.the Departments of Health and Human Services, Labor, and Treasury regarding standards for the use of reference-based pricing structures. Centers for Medicare and Medicaid Services (CMS) on Modifications to the Medicare and Medicaid Electronic Health Record Incentive Programs for 2014 and Revisions to the Certified EHR Technology Definition Proposed Rule. National Quality Forum on its Draft Report: Priority Setting for Performance Measurement: Addressing Performance Measure Gaps for the Health Workforce.
2014 · third_quarter · Health Issues
S. 2529, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014, all provisions S. 2645, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions H.R. 3229, Indian Health Service Advance Appropriations Act of 2013, all provisions S. 1570, Indian Health Service Advance Appropriations Act of 2013, all provisionsH.R. 4843, Native Contract and Rate Expenditure Act of 2014, all provisions H.R. 1701, Cutting Costly Codes Act of 2013, all provisions S. 972, Cutting Costly Codes Act of 2013, all provisions H.R. 3742, Antibiotic Development to Advance Patient Treatment (ADAPT) Act of 2013, all provisions ACA Implementation Prescription requirements for OTC medications Electronic Health Records Meaningful Use Regulations Opioid abuse, diversion control and treatment Prescription drug abuse/pain management/prescriber education Telemedicine ICD-10 Repeal CPT HIPAA Health Care Data Open Payments Regulations (Sunshine Act) Laboratory Developed Tests Personalized Medicine 21st Century Cures Initiative Mental Health Diabetes Nutrition Labeling Drug Compounding Biosimilars Clinical Data Registries Exchanges
Client expense: $4,230,000 · Firm income: Not reported
2014 · third_quarter · Alcohol and Drug Abuse
Public Law 111-152, Health Care and Education Reconciliation Act of 2010, Implementation of addiction treatment issues. Public Law 110-343, Emergency Economic Stabilization Act of 2008, Regulations implementation, Mental health and addiction parity Public Law 111-148, Patient Protection and Affordable Care Act, Implementation of addiction treatment issues. Prescription Drug abuse issues. S.2092/H.R.4288, Opioid Overdose Reduction Act of 2014, Access to Naloxone 100 patient limit for buprenorphine prescribers S.348/H.R.672, Prescription Drug Abuse Prevention and Treatment Act of 2013, Prescription drug abuse related issues S.2504, A bill to address prescription opioid and heroin abuse, generally S.2645, TREAT Act, Addiction treatment and recovery issues S.2839, Comprehensive Addiction and Recovery Act of 2014, Prescription opioid abuse and heroin use treatment issues Addition to #17 below: Center for Substance Abuse Treatment (CSAT)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2014 · third_quarter · Health Issues
SGR : Repeal of the current Medicare Physician Payment Formula including: H.R. 4015/S.2000 : SGR Repeal and Medicare Provider Payment Modernization Act of 2014 Revisions to Face to Face documentation requirements for home care under MedicareCY2015 Home Health Prospective Payment System Rate Update Proposed Rule [CMS-1611-P] Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY2015 [CMS-1612-P] Medicare and Medicaid Programs; Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction; Part II [CMS-3267-F] changes to hospital medical staff rules Medicare Physician Payment Reform Repeal of the SGR HR 4015/S.2000 HR 5539 Legislative changes to the reporting requirements under the Sunshine Act Sunshine Act letter to CMS urging delay in implementation and changes to reporting requirements S. 2964 - Ensuring Access to Primary Care for Women and Children Act. HR 5304 Legislation that would allow Medicare beneficiaries direct access to Audiologists HR 4888 - The Coordinated Recovery Initiative for Babies (CRIB) Act collecting data and developing protocols for treating newborns with Neonatal Abstinence Syndrome S 2645 - The Recovery Enhancement Treatment Act allowing qualified MDs and other health care professionals to treat a greater number of opioid addicted patients with medications
Client expense: $60,000 · Firm income: Not reported
2014 · third_quarter · Alcohol and Drug Abuse
HR 4888 - The Coordinated Recovery Initiative for Babies (CRIB) Act collecting data and developing protocols for treating newborns with Neonatal Abstinence Syndrome S 2645 - The Recovery Enhancement Treatment Act allowing qualified MDs and other health care professionals to treat a greater number of opioid addicted patients with medications
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medicare/Medicaid
SGR : Repeal of the current Medicare Physician Payment Formula including: H.R. 4015/S.2000 : SGR Repeal and Medicare Provider Payment Modernization Act of 2014 Revisions to Face to Face documentation requirements for home care under MedicareCY2015 Home Health Prospective Payment System Rate Update Proposed Rule [CMS-1611-P] Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY2015 [CMS-1612-P] Medicare and Medicaid Programs; Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction; Part II [CMS-3267-F] changes to hospital medical staff rules Medicare Physician Payment Reform Repeal of the SGR HR 4015/S.2000 HR 5539 Legislative changes to the reporting requirements under the Sunshine Act Sunshine Act letter to CMS urging delay in implementation and changes to reporting requirements S. 2964 - Ensuring Access to Primary Care for Women and Children Act. HR 5304 Legislation that would allow Medicare beneficiaries direct access to Audiologists HR 4888 - The Coordinated Recovery Initiative for Babies (CRIB) Act collecting data and developing protocols for treating newborns with Neonatal Abstinence Syndrome S 2645 - The Recovery Enhancement Treatment Act allowing qualified MDs and other health care professionals to treat a greater number of opioid addicted patients with medications
Client expense: $60,000 · Firm income: Not reported
2014 · second_quarter · Tariff (miscellaneous tariff bills)
S.2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S.2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S.2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S.2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS.2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluorpropylene, and vinylidene fluoride. S.2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S.2639 - A bill to suspend temporarily the duty on bisphenol A Bis (3-methacryloyloxypropyl) either substituted dimethacylate. S.2638 - A bill to suspend temporarily the duty on copoly (acrylic acid/itaconic acid). S.2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S.2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon armines, and/or perfluorocarbon ethers. S.2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbon alkanes. S.2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,400,000 · Firm income: Not reported
2014 · first_quarter · Tariff (miscellaneous tariff bills)
S.2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S.2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S.2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S.2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS.2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride. S.2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S.2639 - A bill to suspend temporarily the duty on bisphenol A Bis (3-methacryloyloxypropyl) ether substituted dimethacylate. S.2638 - A bill to suspend temporarily the duty on copoly (acrylic acid/itaconic acid). S.2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S.2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon ethers. S.2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbonalkanes. S.2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,420,000 · Firm income: Not reported
2013 · fourth_quarter · Tariff (miscellaneous tariff bills)
S. 2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S. 2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S. 2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S. 2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS. 2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride. S. 2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S. 2639 - A bill to suspend temporarily the duty on bisphenol A Bis (3-methacryloyloxypropyl) ether substituted dimethacylate. S. 2638 - A bill to suspend temporarily the duty on copoly (acrylic acid/itaconic acid). S. 2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S. 2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon ethers. S. 2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbonalkanes. S. 2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,410,000 · Firm income: Not reported
2013 · third_quarter · Tariff (miscellaneous tariff bills)
S. 2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S. 2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S. 2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S. 2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS. 2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride. S. 2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S. 2639 - A bill to suspend temporarily the duty on bisphenol A Bis (3-methacryloyloxypropyl) ether substituted dimethacylate. S. 2638 - A bill to suspend temporarily the duty on copoly (acrylic acid/itaconic acid). S. 2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S. 2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon ethers. S. 2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbonalkanes. S. 2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,550,000 · Firm income: Not reported
2013 · second_quarter · Tariff (miscellaneous tariff bills)
S. 2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S. 2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S. 2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S. 2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS. 2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride. S. 2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S. 2639 - A bill to suspend temporarily the duty on bisphenol A Bis(3-methacryloyloxypropyl) ether substituted dimethacylate. S. 2638 - A bill to suspend temporarily the duty on copoly(acrylic acid/itaconic acid). S. 2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S. 2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon ethers. S. 2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbonalkanes. S. 2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,460,000 · Firm income: Not reported
2013 · first_quarter · Tariff (miscellaneous tariff bills)
S. 2645 - A bill to extend the temporary suspension of duty on certain catalytic converter mounting mats S. 2644 - A bill to suspend temporarily the duty on certain catalytic converter mats of glass fibers S. 2643 - A bill to extend the temporary suspension of duty on perfluorobutanesulfonyl fluoride S. 2642 - A bill to suspend temporarily the duty on certain polycrystalline fibersS. 2641 - A bill to extend the temporary suspension of duty on fluoropolymers containing 95 percent or more by weight of the monomer units tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride. S. 2640 - A bill to suspend temporarily the duty on potassium persulfate encapsulated in cellulose acetate butyrate. S. 2639 - A bill to suspend temporarily the duty on bisphenol A Bis(3-methacryloyloxypropyl) ether substituted dimethacylate. S. 2638 - A bill to suspend temporarily the duty on copoly(acrylic acid/itaconic acid). S. 2637 - A bill to extend the temporary suspension of duty on C1-3 perfluoroalkyl perfluoromorpholine. S. 2636 - A bill to extend the temporary suspension of duty on mixtures of C5-18 perfluorocarbon alkanes, perfluorocarbon amines, and/or perfluorocarbon ethers. S. 2635 - A bill to extend the temporary suspension of duty on C5-8 perfluorocarbonalkanes. S. 2634 - A bill to extend the temporary suspension of duty on perfluorocarbon amines.
Client expense: $1,230,000 · Firm income: Not reported
| Democratic |
| HI |
| Richard J. Durbin | Democratic | IL |
| Sherrod Brown | Democratic | OH |
Client expense: $39,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Client expense: $1,540,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Drug Enforcement Administration (DEA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
Client expense: $38,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
Client expense: $1,250,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, Veterans Affairs, Dept of (VA), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Federal Highway Administration (FHA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)